Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying pharmaceutical regulatory oversight through a new pharmacist reserve corps, mandatory clinical trial training, and enforcement actions against substandard and falsified medicines. For Nigerian SMBs in healthcare, importation, and distribution, this means stricter compliance requirements and heightened risk of penalties for non-compliant products. Businesses should urgently verify product authenticity, update registrations, and prepare for increased inspections.
Pharmaceuticals
Healthcare
Importation
Distribution
Retail
Clinical Research
Agriculture
Export
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to enhance regulatory capacity and surveillance.
SMBs in pharma distribution and retail may face more frequent inspections and stricter enforcement, but also benefit from improved market integrity.
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
New dates set for mandatory training on clinical trial regulations for stakeholders involved in clinical research.
SMBs conducting or sponsoring clinical trials must ensure staff attend the training to remain compliant and avoid penalties.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC blacklisted Ayrtons Saunders Ltd, UK, and its products for regulatory violations.
Importers and distributors must immediately stop importing or selling products from this company to avoid seizure and legal action.
Public Alert No. 043/2026: NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist
NAFDAC
NAFDAC placed products marketed by Mofus Nigeria Ltd on watchlist pending investigation.
Retailers and distributors should quarantine these products and await further directives to avoid regulatory sanctions.
Public Alert No. 042/2026: Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
NAFDAC
NAFDAC seized suspected substandard and falsified antimalarial medicine BPPL Artemether/Lumefantrine.
Pharmacies and PPMVs must check their stock for this product and remove it immediately to protect consumers and avoid penalties.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
Guide on registering fish farms with NEPC for export purposes.
Fish farming SMBs seeking to export must register with NEPC to access export incentives and comply with regulations.
Increased regulatory scrutiny on pharmaceutical products and supply chains.
Mandatory training for clinical trial stakeholders indicates tighter oversight of research.
Blacklisting and watchlist actions signal zero tolerance for non-compliant products.
Export opportunities for fish farmers through NEPC registration.
Pharmacist reserve group may lead to more frequent market surveillance.
1
Verify all pharmaceutical products against NAFDAC alerts and blacklists.
2
Remove and quarantine any products from Ayrtons Saunders Ltd, Mofus Nigeria Ltd, or the seized BPPL Artemether/Lumefantrine batch.
3
Ensure staff involved in clinical trials attend the mandatory NAFDAC/NHREC training.
4
Register fish farms with NEPC if planning to export.
5
Maintain up-to-date records of product sources and batch numbers for traceability.
6
Subscribe to NAFDAC alerts and updates to stay informed.